PhD research at Utrecht University focused on translating discoveries in chemistry, biology, pharmaceutics, and biomedical sciences into new medicines. You will work on drug targets, bioactive molecules, delivery strategies, and evaluation—often with advanced modalities such as peptides, proteins, nucleotides, and next-generation therapies.
The Drug Innovation PhD program at Utrecht University is dedicated to transforming scientific discoveries in chemistry, biology, pharmaceutics, and biomedical sciences into innovative therapeutic solutions. This program emphasizes the study of drug targets, bioactive molecules, delivery strategies, and their evaluation, often employing advanced modalities such as peptides, proteins, nucleotides, and next-generation therapies.
The program is structured around rigorous research projects within Utrecht University’s Drug Innovation research environment. You will immerse yourself in one of the specialized research groups, receiving robust academic training and supervision throughout your doctoral journey.
Training and Milestones: Throughout your PhD, you will participate in various academic training activities, including workshops on research skills, scientific communication, and professional development, while meeting the milestones set by Utrecht University.
Applicants must possess a Dutch MSc or an equivalent international Master’s degree in Life Sciences, such as Pharmaceutical, Chemical, or Biomedical Sciences. Depending on the focus of the specific research project, relevant theoretical knowledge and laboratory skills are required.
Graduates of the Drug Innovation PhD program are well-prepared for careers in academia, industry, and research institutions. They may pursue roles in drug development, regulatory affairs, or research and development in pharmaceutical companies, contributing to advancements in medical therapies and innovations in healthcare.
Shortlist scholarships and plan your application — free guidance from our advisors.